nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—HRH3—Donepezil—Alzheimer's disease	0.39	0.633	CbGbCtD
Azelastine—CYP2D6—Alzheimer's disease	0.162	1	CbGaD
Azelastine—CYP2A6—Memantine—Alzheimer's disease	0.0541	0.0879	CbGbCtD
Azelastine—CYP2B6—Memantine—Alzheimer's disease	0.0352	0.0572	CbGbCtD
Azelastine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0246	0.0399	CbGbCtD
Azelastine—CYP2C19—Memantine—Alzheimer's disease	0.0224	0.0364	CbGbCtD
Azelastine—CYP2C9—Donepezil—Alzheimer's disease	0.0215	0.0349	CbGbCtD
Azelastine—CYP2D6—Donepezil—Alzheimer's disease	0.0196	0.0319	CbGbCtD
Azelastine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0156	0.0254	CbGbCtD
Azelastine—CYP2D6—Galantamine—Alzheimer's disease	0.0127	0.0206	CbGbCtD
Azelastine—CYP3A4—Donepezil—Alzheimer's disease	0.0125	0.0203	CbGbCtD
Azelastine—CYP3A4—Galantamine—Alzheimer's disease	0.00805	0.0131	CbGbCtD
Azelastine—HRH3—forebrain—Alzheimer's disease	0.00142	0.0973	CbGeAlD
Azelastine—HRH3—telencephalon—Alzheimer's disease	0.0013	0.0895	CbGeAlD
Azelastine—HRH3—nervous system—Alzheimer's disease	0.000769	0.0528	CbGeAlD
Azelastine—HRH3—central nervous system—Alzheimer's disease	0.00074	0.0508	CbGeAlD
Azelastine—HRH3—cerebellum—Alzheimer's disease	0.000723	0.0497	CbGeAlD
Azelastine—Influenza like illness—Memantine—Alzheimer's disease	0.000701	0.00486	CcSEcCtD
Azelastine—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.000698	0.00484	CcSEcCtD
Azelastine—Abnormal vision—Donepezil—Alzheimer's disease	0.000694	0.00481	CcSEcCtD
Azelastine—Influenza like illness—Rivastigmine—Alzheimer's disease	0.000686	0.00476	CcSEcCtD
Azelastine—Mouth ulceration—Memantine—Alzheimer's disease	0.000653	0.00453	CcSEcCtD
Azelastine—Gastroenteritis—Donepezil—Alzheimer's disease	0.000651	0.00452	CcSEcCtD
Azelastine—Eczema—Donepezil—Alzheimer's disease	0.000642	0.00446	CcSEcCtD
Azelastine—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.000639	0.00443	CcSEcCtD
Azelastine—Abnormal vision—Memantine—Alzheimer's disease	0.00063	0.00437	CcSEcCtD
Azelastine—Hyperkinesia—Memantine—Alzheimer's disease	0.00063	0.00437	CcSEcCtD
Azelastine—Mental disability—Memantine—Alzheimer's disease	0.000627	0.00435	CcSEcCtD
Azelastine—Bronchitis—Galantamine—Alzheimer's disease	0.000619	0.00429	CcSEcCtD
Azelastine—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.000616	0.00427	CcSEcCtD
Azelastine—Abnormal vision—Rivastigmine—Alzheimer's disease	0.000616	0.00427	CcSEcCtD
Azelastine—Increased appetite—Donepezil—Alzheimer's disease	0.000614	0.00426	CcSEcCtD
Azelastine—Mental disability—Rivastigmine—Alzheimer's disease	0.000613	0.00425	CcSEcCtD
Azelastine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000609	0.00423	CcSEcCtD
Azelastine—Sleep disorder—Memantine—Alzheimer's disease	0.000606	0.0042	CcSEcCtD
Azelastine—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000598	0.00415	CcSEcCtD
Azelastine—Pollakiuria—Galantamine—Alzheimer's disease	0.000595	0.00413	CcSEcCtD
Azelastine—Arthritis—Donepezil—Alzheimer's disease	0.000594	0.00412	CcSEcCtD
Azelastine—Sleep disorder—Rivastigmine—Alzheimer's disease	0.000592	0.00411	CcSEcCtD
Azelastine—Gastroenteritis—Memantine—Alzheimer's disease	0.000591	0.0041	CcSEcCtD
Azelastine—HRH3—brain—Alzheimer's disease	0.000588	0.0404	CbGeAlD
Azelastine—Eczema—Memantine—Alzheimer's disease	0.000583	0.00405	CcSEcCtD
Azelastine—Eye pain—Memantine—Alzheimer's disease	0.000581	0.00403	CcSEcCtD
Azelastine—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.000579	0.00401	CcSEcCtD
Azelastine—Eczema—Rivastigmine—Alzheimer's disease	0.000571	0.00396	CcSEcCtD
Azelastine—Eye pain—Rivastigmine—Alzheimer's disease	0.000568	0.00394	CcSEcCtD
Azelastine—Increased appetite—Memantine—Alzheimer's disease	0.000558	0.00387	CcSEcCtD
Azelastine—Face oedema—Donepezil—Alzheimer's disease	0.000557	0.00387	CcSEcCtD
Azelastine—Atrial fibrillation—Memantine—Alzheimer's disease	0.000553	0.00384	CcSEcCtD
Azelastine—Urinary retention—Donepezil—Alzheimer's disease	0.000549	0.00381	CcSEcCtD
Azelastine—Haematuria—Galantamine—Alzheimer's disease	0.000547	0.0038	CcSEcCtD
Azelastine—Increased appetite—Rivastigmine—Alzheimer's disease	0.000546	0.00379	CcSEcCtD
Azelastine—Epistaxis—Galantamine—Alzheimer's disease	0.000541	0.00376	CcSEcCtD
Azelastine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000541	0.00375	CcSEcCtD
Azelastine—Arthritis—Memantine—Alzheimer's disease	0.000539	0.00374	CcSEcCtD
Azelastine—Arthritis—Rivastigmine—Alzheimer's disease	0.000528	0.00366	CcSEcCtD
Azelastine—Rhinitis—Galantamine—Alzheimer's disease	0.000517	0.00358	CcSEcCtD
Azelastine—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000516	0.00358	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000509	0.00353	CcSEcCtD
Azelastine—Asthma—Donepezil—Alzheimer's disease	0.000499	0.00346	CcSEcCtD
Azelastine—Urinary retention—Memantine—Alzheimer's disease	0.000498	0.00346	CcSEcCtD
Azelastine—Visual impairment—Galantamine—Alzheimer's disease	0.000497	0.00344	CcSEcCtD
Azelastine—Face oedema—Rivastigmine—Alzheimer's disease	0.000495	0.00343	CcSEcCtD
Azelastine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000488	0.00338	CcSEcCtD
Azelastine—Eye disorder—Galantamine—Alzheimer's disease	0.000482	0.00334	CcSEcCtD
Azelastine—Bronchitis—Donepezil—Alzheimer's disease	0.00048	0.00333	CcSEcCtD
Azelastine—Flushing—Galantamine—Alzheimer's disease	0.000478	0.00332	CcSEcCtD
Azelastine—Nasopharyngitis—Memantine—Alzheimer's disease	0.000469	0.00325	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000462	0.00321	CcSEcCtD
Azelastine—Pollakiuria—Donepezil—Alzheimer's disease	0.000461	0.0032	CcSEcCtD
Azelastine—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000459	0.00318	CcSEcCtD
Azelastine—Weight increased—Donepezil—Alzheimer's disease	0.000454	0.00315	CcSEcCtD
Azelastine—Asthma—Memantine—Alzheimer's disease	0.000453	0.00314	CcSEcCtD
Azelastine—Bronchospasm—Memantine—Alzheimer's disease	0.000446	0.00309	CcSEcCtD
Azelastine—Tension—Galantamine—Alzheimer's disease	0.00044	0.00305	CcSEcCtD
Azelastine—Dysgeusia—Galantamine—Alzheimer's disease	0.000439	0.00305	CcSEcCtD
Azelastine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000436	0.00302	CcSEcCtD
Azelastine—Nervousness—Galantamine—Alzheimer's disease	0.000436	0.00302	CcSEcCtD
Azelastine—Bronchitis—Memantine—Alzheimer's disease	0.000436	0.00302	CcSEcCtD
Azelastine—Back pain—Galantamine—Alzheimer's disease	0.000434	0.00301	CcSEcCtD
Azelastine—Conjunctivitis—Donepezil—Alzheimer's disease	0.000432	0.003	CcSEcCtD
Azelastine—Bronchitis—Rivastigmine—Alzheimer's disease	0.000426	0.00296	CcSEcCtD
Azelastine—Haematuria—Donepezil—Alzheimer's disease	0.000424	0.00294	CcSEcCtD
Azelastine—Vision blurred—Galantamine—Alzheimer's disease	0.000423	0.00293	CcSEcCtD
Azelastine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000421	0.00292	CcSEcCtD
Azelastine—Epistaxis—Donepezil—Alzheimer's disease	0.00042	0.00291	CcSEcCtD
Azelastine—Pollakiuria—Memantine—Alzheimer's disease	0.000419	0.0029	CcSEcCtD
Azelastine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000416	0.00289	CcSEcCtD
Azelastine—Weight increased—Memantine—Alzheimer's disease	0.000412	0.00286	CcSEcCtD
Azelastine—Agitation—Galantamine—Alzheimer's disease	0.000412	0.00286	CcSEcCtD
Azelastine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000412	0.00286	CcSEcCtD
Azelastine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000409	0.00284	CcSEcCtD
Azelastine—ADRA1B—nervous system—Alzheimer's disease	0.000409	0.0281	CbGeAlD
Azelastine—KCNH2—forebrain—Alzheimer's disease	0.000409	0.0281	CbGeAlD
Azelastine—Malaise—Galantamine—Alzheimer's disease	0.000405	0.00281	CcSEcCtD
Azelastine—Weight increased—Rivastigmine—Alzheimer's disease	0.000403	0.0028	CcSEcCtD
Azelastine—Vertigo—Galantamine—Alzheimer's disease	0.000403	0.0028	CcSEcCtD
Azelastine—Mazindol—SLC6A4—Alzheimer's disease	0.000402	0.216	CrCbGaD
Azelastine—Rhinitis—Donepezil—Alzheimer's disease	0.0004	0.00278	CcSEcCtD
Azelastine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000397	0.00276	CcSEcCtD
Azelastine—Palpitations—Galantamine—Alzheimer's disease	0.000396	0.00275	CcSEcCtD
Azelastine—Pharyngitis—Donepezil—Alzheimer's disease	0.000396	0.00275	CcSEcCtD
Azelastine—ADRA1B—central nervous system—Alzheimer's disease	0.000394	0.0271	CbGeAlD
Azelastine—Conjunctivitis—Memantine—Alzheimer's disease	0.000393	0.00272	CcSEcCtD
Azelastine—Cough—Galantamine—Alzheimer's disease	0.000391	0.00272	CcSEcCtD
Azelastine—Hypertension—Galantamine—Alzheimer's disease	0.000387	0.00269	CcSEcCtD
Azelastine—Haematuria—Memantine—Alzheimer's disease	0.000385	0.00267	CcSEcCtD
Azelastine—Visual impairment—Donepezil—Alzheimer's disease	0.000385	0.00267	CcSEcCtD
Azelastine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000384	0.00266	CcSEcCtD
Azelastine—Myalgia—Galantamine—Alzheimer's disease	0.000382	0.00265	CcSEcCtD
Azelastine—Chest pain—Galantamine—Alzheimer's disease	0.000382	0.00265	CcSEcCtD
Azelastine—Epistaxis—Memantine—Alzheimer's disease	0.000381	0.00264	CcSEcCtD
Azelastine—Anxiety—Galantamine—Alzheimer's disease	0.000381	0.00264	CcSEcCtD
Azelastine—Sinusitis—Memantine—Alzheimer's disease	0.000379	0.00263	CcSEcCtD
Azelastine—Loxapine—HTR6—Alzheimer's disease	0.000378	0.204	CrCbGaD
Azelastine—Discomfort—Galantamine—Alzheimer's disease	0.000377	0.00262	CcSEcCtD
Azelastine—Haematuria—Rivastigmine—Alzheimer's disease	0.000377	0.00261	CcSEcCtD
Azelastine—KCNH2—telencephalon—Alzheimer's disease	0.000376	0.0258	CbGeAlD
Azelastine—Dry mouth—Galantamine—Alzheimer's disease	0.000374	0.00259	CcSEcCtD
Azelastine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000373	0.00259	CcSEcCtD
Azelastine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000371	0.00257	CcSEcCtD
Azelastine—Confusional state—Galantamine—Alzheimer's disease	0.000369	0.00256	CcSEcCtD
Azelastine—Rhinitis—Memantine—Alzheimer's disease	0.000364	0.00252	CcSEcCtD
Azelastine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000361	0.0025	CcSEcCtD
Azelastine—Pharyngitis—Memantine—Alzheimer's disease	0.00036	0.0025	CcSEcCtD
Azelastine—Tachycardia—Galantamine—Alzheimer's disease	0.000357	0.00248	CcSEcCtD
Azelastine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000356	0.00247	CcSEcCtD
Azelastine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000353	0.00245	CcSEcCtD
Azelastine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000352	0.00244	CcSEcCtD
Azelastine—Visual impairment—Memantine—Alzheimer's disease	0.000349	0.00242	CcSEcCtD
Azelastine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000342	0.00237	CcSEcCtD
Azelastine—Tension—Donepezil—Alzheimer's disease	0.000341	0.00237	CcSEcCtD
Azelastine—CYP2A6—cerebellum—Alzheimer's disease	0.000341	0.0234	CbGeAlD
Azelastine—Dysgeusia—Donepezil—Alzheimer's disease	0.00034	0.00236	CcSEcCtD
Azelastine—ABCB1—blood vessel—Alzheimer's disease	0.00034	0.0234	CbGeAlD
Azelastine—Eye disorder—Memantine—Alzheimer's disease	0.000339	0.00235	CcSEcCtD
Azelastine—Nervousness—Donepezil—Alzheimer's disease	0.000338	0.00234	CcSEcCtD
Azelastine—Flushing—Memantine—Alzheimer's disease	0.000337	0.00233	CcSEcCtD
Azelastine—Back pain—Donepezil—Alzheimer's disease	0.000336	0.00233	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000334	0.00231	CcSEcCtD
Azelastine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000332	0.0023	CcSEcCtD
Azelastine—Flushing—Rivastigmine—Alzheimer's disease	0.000329	0.00228	CcSEcCtD
Azelastine—Paraesthesia—Galantamine—Alzheimer's disease	0.000329	0.00228	CcSEcCtD
Azelastine—HRH1—forebrain—Alzheimer's disease	0.000328	0.0225	CbGeAlD
Azelastine—Vision blurred—Donepezil—Alzheimer's disease	0.000328	0.00227	CcSEcCtD
Azelastine—Clemastine—CYP2D6—Alzheimer's disease	0.000326	0.175	CrCbGaD
Azelastine—Somnolence—Galantamine—Alzheimer's disease	0.000325	0.00226	CcSEcCtD
Azelastine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000323	0.00224	CcSEcCtD
Azelastine—Agitation—Donepezil—Alzheimer's disease	0.000319	0.00222	CcSEcCtD
Azelastine—Clozapine—HTR6—Alzheimer's disease	0.000318	0.171	CrCbGaD
Azelastine—Fatigue—Galantamine—Alzheimer's disease	0.000316	0.00219	CcSEcCtD
Azelastine—Malaise—Donepezil—Alzheimer's disease	0.000314	0.00217	CcSEcCtD
Azelastine—Constipation—Galantamine—Alzheimer's disease	0.000313	0.00217	CcSEcCtD
Azelastine—ADRA1B—brain—Alzheimer's disease	0.000313	0.0215	CbGeAlD
Azelastine—Vertigo—Donepezil—Alzheimer's disease	0.000312	0.00217	CcSEcCtD
Azelastine—Tension—Memantine—Alzheimer's disease	0.00031	0.00215	CcSEcCtD
Azelastine—Dysgeusia—Memantine—Alzheimer's disease	0.000309	0.00214	CcSEcCtD
Azelastine—Nervousness—Memantine—Alzheimer's disease	0.000307	0.00213	CcSEcCtD
Azelastine—Back pain—Memantine—Alzheimer's disease	0.000305	0.00212	CcSEcCtD
Azelastine—Cough—Donepezil—Alzheimer's disease	0.000303	0.0021	CcSEcCtD
Azelastine—Tension—Rivastigmine—Alzheimer's disease	0.000303	0.0021	CcSEcCtD
Azelastine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000302	0.0021	CcSEcCtD
Azelastine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000302	0.00209	CcSEcCtD
Azelastine—HRH1—telencephalon—Alzheimer's disease	0.000302	0.0207	CbGeAlD
Azelastine—Hypertension—Donepezil—Alzheimer's disease	0.0003	0.00208	CcSEcCtD
Azelastine—Nervousness—Rivastigmine—Alzheimer's disease	0.0003	0.00208	CcSEcCtD
Azelastine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000299	0.00208	CcSEcCtD
Azelastine—Back pain—Rivastigmine—Alzheimer's disease	0.000299	0.00207	CcSEcCtD
Azelastine—Vision blurred—Memantine—Alzheimer's disease	0.000297	0.00206	CcSEcCtD
Azelastine—Myalgia—Donepezil—Alzheimer's disease	0.000296	0.00205	CcSEcCtD
Azelastine—Chest pain—Donepezil—Alzheimer's disease	0.000296	0.00205	CcSEcCtD
Azelastine—Anxiety—Donepezil—Alzheimer's disease	0.000295	0.00205	CcSEcCtD
Azelastine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000293	0.00203	CcSEcCtD
Azelastine—Discomfort—Donepezil—Alzheimer's disease	0.000292	0.00203	CcSEcCtD
Azelastine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000291	0.00202	CcSEcCtD
Azelastine—Agitation—Memantine—Alzheimer's disease	0.00029	0.00201	CcSEcCtD
Azelastine—CYP2E1—telencephalon—Alzheimer's disease	0.00029	0.0199	CbGeAlD
Azelastine—Dry mouth—Donepezil—Alzheimer's disease	0.000289	0.00201	CcSEcCtD
Azelastine—Abdominal pain—Galantamine—Alzheimer's disease	0.000289	0.00201	CcSEcCtD
Azelastine—Body temperature increased—Galantamine—Alzheimer's disease	0.000289	0.00201	CcSEcCtD
Azelastine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000287	0.00199	CcSEcCtD
Azelastine—Confusional state—Donepezil—Alzheimer's disease	0.000286	0.00198	CcSEcCtD
Azelastine—Malaise—Memantine—Alzheimer's disease	0.000285	0.00197	CcSEcCtD
Azelastine—Agitation—Rivastigmine—Alzheimer's disease	0.000284	0.00197	CcSEcCtD
Azelastine—Vertigo—Memantine—Alzheimer's disease	0.000284	0.00197	CcSEcCtD
Azelastine—Infection—Donepezil—Alzheimer's disease	0.000282	0.00196	CcSEcCtD
Azelastine—Palpitations—Memantine—Alzheimer's disease	0.000279	0.00193	CcSEcCtD
Azelastine—Malaise—Rivastigmine—Alzheimer's disease	0.000278	0.00193	CcSEcCtD
Azelastine—Vertigo—Rivastigmine—Alzheimer's disease	0.000277	0.00192	CcSEcCtD
Azelastine—CYP2A6—brain—Alzheimer's disease	0.000277	0.019	CbGeAlD
Azelastine—Cough—Memantine—Alzheimer's disease	0.000275	0.00191	CcSEcCtD
Azelastine—Palpitations—Rivastigmine—Alzheimer's disease	0.000273	0.00189	CcSEcCtD
Azelastine—Hypertension—Memantine—Alzheimer's disease	0.000273	0.00189	CcSEcCtD
Azelastine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00027	0.00187	CcSEcCtD
Azelastine—Cough—Rivastigmine—Alzheimer's disease	0.000269	0.00187	CcSEcCtD
Azelastine—Chest pain—Memantine—Alzheimer's disease	0.000269	0.00186	CcSEcCtD
Azelastine—Myalgia—Memantine—Alzheimer's disease	0.000269	0.00186	CcSEcCtD
Azelastine—Anxiety—Memantine—Alzheimer's disease	0.000268	0.00186	CcSEcCtD
Azelastine—Hypertension—Rivastigmine—Alzheimer's disease	0.000267	0.00185	CcSEcCtD
Azelastine—Discomfort—Memantine—Alzheimer's disease	0.000266	0.00184	CcSEcCtD
Azelastine—Chest pain—Rivastigmine—Alzheimer's disease	0.000263	0.00182	CcSEcCtD
Azelastine—Myalgia—Rivastigmine—Alzheimer's disease	0.000263	0.00182	CcSEcCtD
Azelastine—Dry mouth—Memantine—Alzheimer's disease	0.000263	0.00182	CcSEcCtD
Azelastine—Asthenia—Galantamine—Alzheimer's disease	0.000263	0.00182	CcSEcCtD
Azelastine—Anxiety—Rivastigmine—Alzheimer's disease	0.000262	0.00182	CcSEcCtD
Azelastine—Confusional state—Memantine—Alzheimer's disease	0.00026	0.0018	CcSEcCtD
Azelastine—Discomfort—Rivastigmine—Alzheimer's disease	0.00026	0.0018	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000259	0.00179	CcSEcCtD
Azelastine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000257	0.00178	CcSEcCtD
Azelastine—Infection—Memantine—Alzheimer's disease	0.000256	0.00178	CcSEcCtD
Azelastine—Paraesthesia—Donepezil—Alzheimer's disease	0.000255	0.00177	CcSEcCtD
Azelastine—Confusional state—Rivastigmine—Alzheimer's disease	0.000254	0.00176	CcSEcCtD
Azelastine—Dyspnoea—Donepezil—Alzheimer's disease	0.000253	0.00175	CcSEcCtD
Azelastine—Somnolence—Donepezil—Alzheimer's disease	0.000252	0.00175	CcSEcCtD
Azelastine—Tachycardia—Memantine—Alzheimer's disease	0.000251	0.00174	CcSEcCtD
Azelastine—Diarrhoea—Galantamine—Alzheimer's disease	0.000251	0.00174	CcSEcCtD
Azelastine—Infection—Rivastigmine—Alzheimer's disease	0.00025	0.00174	CcSEcCtD
Azelastine—CYP2D6—forebrain—Alzheimer's disease	0.00025	0.0171	CbGeAlD
Azelastine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000246	0.00171	CcSEcCtD
Azelastine—Fatigue—Donepezil—Alzheimer's disease	0.000245	0.0017	CcSEcCtD
Azelastine—Constipation—Donepezil—Alzheimer's disease	0.000243	0.00168	CcSEcCtD
Azelastine—Pain—Donepezil—Alzheimer's disease	0.000243	0.00168	CcSEcCtD
Azelastine—Dizziness—Galantamine—Alzheimer's disease	0.000242	0.00168	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000235	0.00163	CcSEcCtD
Azelastine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000234	0.00162	CcSEcCtD
Azelastine—Vomiting—Galantamine—Alzheimer's disease	0.000233	0.00161	CcSEcCtD
Azelastine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000232	0.00161	CcSEcCtD
Azelastine—Paraesthesia—Memantine—Alzheimer's disease	0.000231	0.0016	CcSEcCtD
Azelastine—Rash—Galantamine—Alzheimer's disease	0.000231	0.0016	CcSEcCtD
Azelastine—Dermatitis—Galantamine—Alzheimer's disease	0.000231	0.0016	CcSEcCtD
Azelastine—Dyspnoea—Memantine—Alzheimer's disease	0.00023	0.00159	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00023	0.00159	CcSEcCtD
Azelastine—CYP2D6—telencephalon—Alzheimer's disease	0.000229	0.0158	CbGeAlD
Azelastine—Headache—Galantamine—Alzheimer's disease	0.000229	0.00159	CcSEcCtD
Azelastine—Somnolence—Memantine—Alzheimer's disease	0.000229	0.00159	CcSEcCtD
Azelastine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000226	0.00157	CcSEcCtD
Azelastine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000225	0.00156	CcSEcCtD
Azelastine—Abdominal pain—Donepezil—Alzheimer's disease	0.000224	0.00156	CcSEcCtD
Azelastine—Body temperature increased—Donepezil—Alzheimer's disease	0.000224	0.00156	CcSEcCtD
Azelastine—Somnolence—Rivastigmine—Alzheimer's disease	0.000224	0.00155	CcSEcCtD
Azelastine—KCNH2—nervous system—Alzheimer's disease	0.000222	0.0153	CbGeAlD
Azelastine—Fatigue—Memantine—Alzheimer's disease	0.000222	0.00154	CcSEcCtD
Azelastine—Pain—Memantine—Alzheimer's disease	0.00022	0.00153	CcSEcCtD
Azelastine—Constipation—Memantine—Alzheimer's disease	0.00022	0.00153	CcSEcCtD
Azelastine—Nausea—Galantamine—Alzheimer's disease	0.000217	0.00151	CcSEcCtD
Azelastine—Fatigue—Rivastigmine—Alzheimer's disease	0.000217	0.00151	CcSEcCtD
Azelastine—Pain—Rivastigmine—Alzheimer's disease	0.000216	0.00149	CcSEcCtD
Azelastine—Constipation—Rivastigmine—Alzheimer's disease	0.000216	0.00149	CcSEcCtD
Azelastine—KCNH2—central nervous system—Alzheimer's disease	0.000214	0.0147	CbGeAlD
Azelastine—Feeling abnormal—Memantine—Alzheimer's disease	0.000212	0.00147	CcSEcCtD
Azelastine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000211	0.00146	CcSEcCtD
Azelastine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000209	0.00145	CcSEcCtD
Azelastine—KCNH2—cerebellum—Alzheimer's disease	0.000209	0.0144	CbGeAlD
Azelastine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000208	0.00144	CcSEcCtD
Azelastine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000206	0.00143	CcSEcCtD
Azelastine—Abdominal pain—Memantine—Alzheimer's disease	0.000204	0.00141	CcSEcCtD
Azelastine—Body temperature increased—Memantine—Alzheimer's disease	0.000204	0.00141	CcSEcCtD
Azelastine—Asthenia—Donepezil—Alzheimer's disease	0.000204	0.00141	CcSEcCtD
Azelastine—ABCB1—embryo—Alzheimer's disease	0.000203	0.0139	CbGeAlD
Azelastine—Pruritus—Donepezil—Alzheimer's disease	0.000201	0.00139	CcSEcCtD
Azelastine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000199	0.00138	CcSEcCtD
Azelastine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000199	0.00138	CcSEcCtD
Azelastine—Diarrhoea—Donepezil—Alzheimer's disease	0.000194	0.00135	CcSEcCtD
Azelastine—Hypersensitivity—Memantine—Alzheimer's disease	0.00019	0.00132	CcSEcCtD
Azelastine—Dizziness—Donepezil—Alzheimer's disease	0.000188	0.0013	CcSEcCtD
Azelastine—CYP1A1—nervous system—Alzheimer's disease	0.000188	0.0129	CbGeAlD
Azelastine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000186	0.00129	CcSEcCtD
Azelastine—Asthenia—Memantine—Alzheimer's disease	0.000185	0.00128	CcSEcCtD
Azelastine—CYP2B6—nervous system—Alzheimer's disease	0.000182	0.0125	CbGeAlD
Azelastine—Pruritus—Memantine—Alzheimer's disease	0.000182	0.00126	CcSEcCtD
Azelastine—Asthenia—Rivastigmine—Alzheimer's disease	0.000181	0.00125	CcSEcCtD
Azelastine—CYP1A1—central nervous system—Alzheimer's disease	0.000181	0.0124	CbGeAlD
Azelastine—Vomiting—Donepezil—Alzheimer's disease	0.00018	0.00125	CcSEcCtD
Azelastine—ABCB1—forebrain—Alzheimer's disease	0.000179	0.0123	CbGeAlD
Azelastine—Rash—Donepezil—Alzheimer's disease	0.000179	0.00124	CcSEcCtD
Azelastine—Dermatitis—Donepezil—Alzheimer's disease	0.000179	0.00124	CcSEcCtD
Azelastine—Pruritus—Rivastigmine—Alzheimer's disease	0.000178	0.00124	CcSEcCtD
Azelastine—HRH1—nervous system—Alzheimer's disease	0.000178	0.0122	CbGeAlD
Azelastine—Headache—Donepezil—Alzheimer's disease	0.000178	0.00123	CcSEcCtD
Azelastine—Diarrhoea—Memantine—Alzheimer's disease	0.000176	0.00122	CcSEcCtD
Azelastine—CYP2B6—central nervous system—Alzheimer's disease	0.000176	0.0121	CbGeAlD
Azelastine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000172	0.0012	CcSEcCtD
Azelastine—HRH1—central nervous system—Alzheimer's disease	0.000171	0.0118	CbGeAlD
Azelastine—CYP2E1—nervous system—Alzheimer's disease	0.000171	0.0118	CbGeAlD
Azelastine—Dizziness—Memantine—Alzheimer's disease	0.00017	0.00118	CcSEcCtD
Azelastine—KCNH2—brain—Alzheimer's disease	0.00017	0.0117	CbGeAlD
Azelastine—Nausea—Donepezil—Alzheimer's disease	0.000169	0.00117	CcSEcCtD
Azelastine—Dizziness—Rivastigmine—Alzheimer's disease	0.000167	0.00116	CcSEcCtD
Azelastine—ABCB1—telencephalon—Alzheimer's disease	0.000165	0.0113	CbGeAlD
Azelastine—CYP2E1—central nervous system—Alzheimer's disease	0.000165	0.0113	CbGeAlD
Azelastine—Vomiting—Memantine—Alzheimer's disease	0.000164	0.00114	CcSEcCtD
Azelastine—Rash—Memantine—Alzheimer's disease	0.000162	0.00113	CcSEcCtD
Azelastine—Dermatitis—Memantine—Alzheimer's disease	0.000162	0.00113	CcSEcCtD
Azelastine—Headache—Memantine—Alzheimer's disease	0.000161	0.00112	CcSEcCtD
Azelastine—CYP2E1—cerebellum—Alzheimer's disease	0.000161	0.0111	CbGeAlD
Azelastine—Vomiting—Rivastigmine—Alzheimer's disease	0.00016	0.00111	CcSEcCtD
Azelastine—Rash—Rivastigmine—Alzheimer's disease	0.000159	0.0011	CcSEcCtD
Azelastine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000159	0.0011	CcSEcCtD
Azelastine—Headache—Rivastigmine—Alzheimer's disease	0.000158	0.0011	CcSEcCtD
Azelastine—CYP2C8—brain—Alzheimer's disease	0.000155	0.0107	CbGeAlD
Azelastine—Nausea—Memantine—Alzheimer's disease	0.000153	0.00106	CcSEcCtD
Azelastine—Nausea—Rivastigmine—Alzheimer's disease	0.00015	0.00104	CcSEcCtD
Azelastine—Loxapine—SLC6A4—Alzheimer's disease	0.000145	0.0779	CrCbGaD
Azelastine—CYP1A1—brain—Alzheimer's disease	0.000143	0.00985	CbGeAlD
Azelastine—CYP2B6—brain—Alzheimer's disease	0.000139	0.00957	CbGeAlD
Azelastine—CYP3A4—nervous system—Alzheimer's disease	0.000138	0.00946	CbGeAlD
Azelastine—HRH1—brain—Alzheimer's disease	0.000136	0.00935	CbGeAlD
Azelastine—CYP2D6—nervous system—Alzheimer's disease	0.000135	0.00931	CbGeAlD
Azelastine—CYP3A4—central nervous system—Alzheimer's disease	0.000133	0.0091	CbGeAlD
Azelastine—CYP2E1—brain—Alzheimer's disease	0.000131	0.00898	CbGeAlD
Azelastine—CYP2D6—central nervous system—Alzheimer's disease	0.00013	0.00896	CbGeAlD
Azelastine—CYP2D6—cerebellum—Alzheimer's disease	0.000127	0.00876	CbGeAlD
Azelastine—Loxapine—HTR2A—Alzheimer's disease	0.000111	0.0599	CrCbGaD
Azelastine—CYP2D6—brain—Alzheimer's disease	0.000104	0.00711	CbGeAlD
Azelastine—ABCB1—nervous system—Alzheimer's disease	9.74e-05	0.00669	CbGeAlD
Azelastine—ABCB1—central nervous system—Alzheimer's disease	9.38e-05	0.00644	CbGeAlD
Azelastine—Clozapine—HTR2A—Alzheimer's disease	9.35e-05	0.0503	CrCbGaD
Azelastine—ABCB1—cerebellum—Alzheimer's disease	9.17e-05	0.0063	CbGeAlD
Azelastine—Clozapine—CYP2D6—Alzheimer's disease	8.55e-05	0.046	CrCbGaD
Azelastine—ABCB1—brain—Alzheimer's disease	7.45e-05	0.00512	CbGeAlD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.6e-06	9.05e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	5.57e-06	9.02e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.56e-06	9e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	5.55e-06	8.98e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	5.53e-06	8.94e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—A2M—Alzheimer's disease	5.52e-06	8.93e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	5.51e-06	8.91e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	5.5e-06	8.9e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	5.48e-06	8.87e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	5.47e-06	8.85e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	5.46e-06	8.83e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	5.46e-06	8.83e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	5.45e-06	8.81e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	5.38e-06	8.7e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	5.37e-06	8.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	5.36e-06	8.66e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	5.31e-06	8.6e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.31e-06	8.59e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.31e-06	8.59e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—APOE—Alzheimer's disease	5.3e-06	8.57e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	5.26e-06	8.52e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	5.26e-06	8.52e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	5.25e-06	8.49e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—BCHE—Alzheimer's disease	5.24e-06	8.47e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	5.22e-06	8.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	5.2e-06	8.41e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	5.17e-06	8.36e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	5.16e-06	8.35e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—Alzheimer's disease	5.16e-06	8.35e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	5.15e-06	8.33e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—LPL—Alzheimer's disease	5.1e-06	8.25e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	5.07e-06	8.21e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	5.06e-06	8.19e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—LPL—Alzheimer's disease	4.99e-06	8.08e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	4.99e-06	8.07e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—LPL—Alzheimer's disease	4.98e-06	8.06e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.97e-06	8.04e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	4.97e-06	8.03e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.94e-06	8e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	4.94e-06	7.99e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.94e-06	7.99e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.92e-06	7.96e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.91e-06	7.94e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	4.89e-06	7.92e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	4.85e-06	7.84e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	4.8e-06	7.77e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.79e-06	7.75e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.78e-06	7.73e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.78e-06	7.73e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	4.74e-06	7.68e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	4.74e-06	7.67e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—Alzheimer's disease	4.72e-06	7.64e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	4.72e-06	7.64e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	4.72e-06	7.63e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—LPL—Alzheimer's disease	4.71e-06	7.61e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.66e-06	7.54e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	4.63e-06	7.5e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.62e-06	7.47e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	4.62e-06	7.47e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	4.62e-06	7.47e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	4.61e-06	7.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	4.59e-06	7.43e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	4.59e-06	7.42e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.58e-06	7.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	4.57e-06	7.4e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.53e-06	7.33e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—INS—Alzheimer's disease	4.52e-06	7.32e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.51e-06	7.3e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.5e-06	7.28e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.5e-06	7.28e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.5e-06	7.27e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	4.49e-06	7.27e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.49e-06	7.26e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.48e-06	7.24e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.41e-06	7.14e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.41e-06	7.13e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	4.41e-06	7.13e-05	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—AKT1—Alzheimer's disease	4.36e-06	7.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	4.35e-06	7.04e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—LPL—Alzheimer's disease	4.31e-06	6.98e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	4.29e-06	6.94e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOE—Alzheimer's disease	4.27e-06	6.91e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.26e-06	6.89e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.26e-06	6.89e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	4.24e-06	6.86e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	4.23e-06	6.85e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	4.23e-06	6.84e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	4.21e-06	6.81e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	4.2e-06	6.79e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.19e-06	6.79e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	4.19e-06	6.78e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOE—Alzheimer's disease	4.18e-06	6.77e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.18e-06	6.77e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.18e-06	6.76e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.18e-06	6.76e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOE—Alzheimer's disease	4.18e-06	6.76e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	4.15e-06	6.71e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.14e-06	6.7e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	4.14e-06	6.69e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.13e-06	6.68e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.11e-06	6.65e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	4e-06	6.47e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	3.99e-06	6.46e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	3.97e-06	6.42e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	3.97e-06	6.42e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.96e-06	6.41e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.95e-06	6.38e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.95e-06	6.38e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	3.94e-06	6.38e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—F2—Alzheimer's disease	3.94e-06	6.38e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.91e-06	6.32e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.89e-06	6.3e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.89e-06	6.29e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	3.88e-06	6.28e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.87e-06	6.27e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.87e-06	6.26e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.86e-06	6.24e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.86e-06	6.24e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.85e-06	6.23e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.84e-06	6.21e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.82e-06	6.19e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	3.82e-06	6.17e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—LPL—Alzheimer's disease	3.76e-06	6.08e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	3.72e-06	6.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.7e-06	5.99e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.66e-06	5.92e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—INS—Alzheimer's disease	3.65e-06	5.9e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.64e-06	5.9e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.64e-06	5.88e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CALM1—Alzheimer's disease	3.63e-06	5.87e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	3.63e-06	5.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.62e-06	5.86e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—Alzheimer's disease	3.62e-06	5.85e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.59e-06	5.81e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAV1—Alzheimer's disease	3.58e-06	5.8e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—INS—Alzheimer's disease	3.57e-06	5.78e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.57e-06	5.78e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—INS—Alzheimer's disease	3.57e-06	5.77e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.54e-06	5.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.51e-06	5.68e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.51e-06	5.68e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.47e-06	5.62e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.47e-06	5.62e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.47e-06	5.61e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	3.46e-06	5.6e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.45e-06	5.59e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.44e-06	5.56e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.4e-06	5.51e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.38e-06	5.48e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—INS—Alzheimer's disease	3.37e-06	5.45e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.3e-06	5.33e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.28e-06	5.31e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.24e-06	5.24e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.23e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.23e-06	5.22e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	3.2e-06	5.18e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.2e-06	5.18e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.19e-06	5.16e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.16e-06	5.12e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	3.16e-06	5.12e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—Alzheimer's disease	3.15e-06	5.1e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARG—Alzheimer's disease	3.15e-06	5.1e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.13e-06	5.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.13e-06	5.07e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	3.13e-06	5.06e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.12e-06	5.05e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—INS—Alzheimer's disease	3.09e-06	5e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.05e-06	4.93e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3e-06	4.86e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.98e-06	4.82e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.97e-06	4.8e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.96e-06	4.8e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.96e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.95e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.95e-06	4.78e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.94e-06	4.76e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.94e-06	4.76e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.94e-06	4.75e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	2.93e-06	4.74e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.92e-06	4.72e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.92e-06	4.72e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	2.87e-06	4.64e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.86e-06	4.63e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.81e-06	4.55e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—INS—Alzheimer's disease	2.76e-06	4.46e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.74e-06	4.44e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.71e-06	4.38e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.7e-06	4.37e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.7e-06	4.37e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.7e-06	4.37e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—INS—Alzheimer's disease	2.69e-06	4.36e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.69e-06	4.35e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.68e-06	4.34e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.66e-06	4.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.64e-06	4.27e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.59e-06	4.18e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.56e-06	4.15e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.54e-06	4.12e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.54e-06	4.1e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.53e-06	4.1e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.52e-06	4.08e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.52e-06	4.07e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.51e-06	4.07e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.49e-06	4.03e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.49e-06	4.03e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	2.48e-06	4.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.44e-06	3.95e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.44e-06	3.94e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.42e-06	3.91e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.36e-06	3.82e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.32e-06	3.75e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-06	3.7e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.26e-06	3.65e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.22e-06	3.6e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.21e-06	3.58e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.21e-06	3.57e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.19e-06	3.54e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.16e-06	3.49e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.15e-06	3.48e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.09e-06	3.37e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.07e-06	3.35e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.03e-06	3.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.02e-06	3.26e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.95e-06	3.15e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.94e-06	3.14e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.92e-06	3.11e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.88e-06	3.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.88e-06	3.05e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	1.82e-06	2.95e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.72e-06	2.79e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.72e-06	2.79e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.7e-06	2.76e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.69e-06	2.74e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.66e-06	2.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-06	2.57e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.56e-06	2.52e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.47e-06	2.38e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.45e-06	2.35e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.44e-06	2.33e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.44e-06	2.33e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.44e-06	2.33e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.36e-06	2.2e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.33e-06	2.15e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.25e-06	2.02e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.11e-06	1.8e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.09e-06	1.76e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.02e-06	1.65e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.01e-06	1.64e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	8.66e-07	1.4e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.69e-07	1.08e-05	CbGpPWpGaD
